HC
TMO icon

HNP Capital’s Thermo Fisher Scientific TMO Stock Holding History

HNP Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$4.88M Sell
8,473
-139
-2% -$78.3K 1.36% 14
2022
Q4 		$4.74M Buy
8,612
+259
+3% +$137K 1.33% 15
2022
Q3 		$4.24M Sell
8,353
-105
-1% -$58.8K 1.22% 15
2022
Q2 		$4.59M Sell
8,458
-58
-0.7% -$31.9K 1.26% 17
2022
Q1 		$5.03M Sell
8,516
-510
-6% -$293K 1.19% 20
2021
Q4 		$6.02M Buy
9,026
+53
+0.6% +$33.1K 1.36% 21
2021
Q3 		$5.13M Buy
8,973
+171
+2% +$93.9K 1.28% 20
2021
Q2 		$4.44M Buy
8,802
+206
+2% +$97.2K 1.17% 28
2021
Q1 		$3.92M Buy
8,596
+104
+1% +$49.6K 1.16% 24
2020
Q4 		$3.96M Buy
8,492
+132
+2% +$61.9K 1.29% 20
2020
Q3 		$4.41M Sell
8,360
-101
-1% -$41.7K 1.62% 15
2020
Q2 		$3.1M Buy
8,461
+6,908
+445% +$2.32M 1.28% 22
2020
Q1 		$496K Sell
1,553
-3,766
-71% -$1.19M 0.07% 143
2019
Q4 		$1.75M Buy
5,319
+1,174
+28% +$356K 0.75% 36
2019
Q3 		$1.17M Hold
4,145
– – 0.64% 38
2019
Q2 		$1.22M Hold
4,145
– – 0.71% 37
2019
Q1 		$1.14M Sell
4,145
-60
-1% -$14.9K 0.71% 39
2018
Q4 		$941K Buy
+4,205
New +$987K 0.63% 43

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HNP Capital's TMO Position: Q1 2023 in Review

HNP Capital reduced its Thermo Fisher Scientific (TMO) stake by 1.6% in Q1 2023, selling an estimated $78.3K and leaving 8,473 shares worth $4.88M. The position accounts for 1.36% of the portfolio, ranked #14.

HNP Capital first reported a position in TMO in Q4 2018 and has held it in 18 quarters since. The position peaked at $6.02M in Q4 2021. 2,385 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • HNP Capital held 8,473 shares of Thermo Fisher Scientific worth $4.88M as of Q1 2023.
  • HNP Capital sold 139 Thermo Fisher Scientific shares in Q1 2023, an estimated $78.3K.
  • Thermo Fisher Scientific made up 1.36% of HNP Capital's portfolio in Q1 2023, its #14 holding.
  • HNP Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 18 quarters since.
  • HNP Capital's Thermo Fisher Scientific position peaked at $6.02M in Q4 2021.
  • 2,385 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.